Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 10555007)

Published in Am J Surg Pathol on November 01, 1999

Authors

K A Cataldo1, S M Jalal, M E Law, S M Ansell, D J Inwards, M Fine, D A Arber, K A Pulford, J G Strickler

Author Affiliations

1: Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.

Articles citing this

A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clin Cancer Res (2010) 4.51

The biology and treatment of EML4-ALK non-small cell lung cancer. Eur J Cancer (2010) 3.03

FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn (2006) 2.28

Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond. Drug Des Devel Ther (2011) 1.57

A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. Am J Pathol (2002) 1.32

Molecular diagnostic approach to non-Hodgkin's lymphoma. J Mol Diagn (2000) 1.19

Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. J Clin Oncol (2008) 1.00

The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts. J Mol Histol (2006) 0.86

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. Clin Cancer Res (2015) 0.85

Crizotinib in the treatment of non-small-cell lung carcinoma. Contemp Oncol (Pozn) (2013) 0.78

Clinical Significance of ALK-1 Gene Abnormalities in Diffuse Large Cell Lymphoma. Clin Med Insights Oncol (2012) 0.77

Primary Cutaneous CD30-Positive Large T-Cell Lymphoma in an 80-Year-Old Man: A Case Report. ISRN Dermatol (2011) 0.77

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors. Transl Lung Cancer Res (2016) 0.76

Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer. Drugs Future (2011) 0.75

Articles by these authors

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48

Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol (1990) 4.42

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04

Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med (1999) 3.37

Acquired C1 esterase inhibitor deficiency. Ann Intern Med (2000) 3.27

Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol (1987) 2.74

A mutant neomycin phosphotransferase II gene reduces the resistance of transformants to antibiotic selection pressure. Proc Natl Acad Sci U S A (1990) 2.50

Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms. Lancet (1984) 2.25

Extramedullary myeloid cell tumors. An immunohistochemical and morphologic study of 28 cases. Am J Surg Pathol (1993) 2.20

Splenic vascular tumors: a histologic, immunophenotypic, and virologic study. Am J Surg Pathol (1997) 2.09

Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer (2000) 1.95

Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study. Leukemia (2011) 1.92

Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol (2001) 1.91

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma. Leukemia (2010) 1.81

Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A (1997) 1.79

Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas. Leukemia (2007) 1.79

Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim Biophys Acta (2001) 1.78

Pancreatic lymphoma: is it a surgical disease? Pancreas (1994) 1.77

Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer (1985) 1.76

Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia (2008) 1.75

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood (2001) 1.74

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood (2000) 1.74

Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease). Arch Pathol Lab Med (1996) 1.67

Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation. Br J Dermatol (1985) 1.58

Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol (2000) 1.58

Euchromatic 9q + heteromorphism in a family. Am J Med Genet (1990) 1.52

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma. Leukemia (2005) 1.51

Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum Pathol (1989) 1.51

The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia (2011) 1.50

Role of endosymbiotic zooxanthellae and coral mucus in the adhesion of the coral-bleaching pathogen Vibrio shiloi to its host. FEMS Microbiol Lett (2001) 1.48

Combined histochemical stains in the differential diagnosis of Cryptococcus neoformans. Mod Pathol (1993) 1.48

Utility of multicolor fluorescent in situ hybridization in clinical cytogenetics. Genet Med (2001) 1.45

Immunoglobulin gene rearrangements in Hodgkin's disease. Hum Pathol (1986) 1.43

Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol (2001) 1.43

Fuchs' endothelial dystrophy of the cornea. 29th Sanford Gifford Memorial lecture. Am J Ophthalmol (1974) 1.43

Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. Am J Surg Pathol (1997) 1.42

Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol (2013) 1.41

Osseous Hodgkin disease. Cancer (1999) 1.41

Monoclonal antibody (Y1/82A) with specificity towards peripheral blood monocytes and tissue macrophages. J Clin Pathol (1988) 1.41

Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis (1995) 1.39

The effect of decalcification on in situ hybridization. Mod Pathol (1997) 1.39

Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations. Leukemia (2006) 1.39

Relation of donor age to success in penetrating keratoplasty. Arch Ophthalmol (1971) 1.35

A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies. Cancer Genet Cytogenet (1998) 1.34

Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol (1986) 1.32

Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant (2001) 1.31

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate. Bone Marrow Transplant (2004) 1.26

The human gut contains a novel population of B lymphocytes which resemble marginal zone cells. Clin Exp Immunol (1985) 1.24

Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues. Am J Pathol (1987) 1.23

Human lung tumours: a correlation of antigenic profile with histological type. Histopathology (1985) 1.22

Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood (1998) 1.22

The "syncytial variant" of nodular sclerosing Hodgkin's disease. Am J Surg Pathol (1986) 1.22

Partial trisomy 7p associated with familial 7p;22q translocation. J Med Genet (1977) 1.21

Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med (2000) 1.20

Detection of normal and chimeric nucleophosmin in human cells. Blood (1999) 1.20

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. Br J Cancer (2010) 1.19

Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1. Am J Pathol (1989) 1.19

The distribution of immunoreactive interferon-alpha in normal human tissues. Immunology (1989) 1.18

The prognosis for keratoplasty in keratoconus. Ophthalmology (1982) 1.18

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia. Leukemia (2003) 1.18

Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody. Hum Pathol (1987) 1.17

Effect of prophylactic antibiotics in acute nonperforated appendicitis: a prospective, randomized, double-blind clinical study. Ann Surg (1981) 1.17

Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma. Bone Marrow Transplant (2006) 1.15

Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors. Mol Immunol (1991) 1.14

Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch Biochem Biophys (1998) 1.13

The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol (1991) 1.12

Long-term changes in corneal endothelium following penetrating keratoplasty. A specular microscopic study. Ophthalmology (1983) 1.12

An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours. J Clin Pathol (1985) 1.12

Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications. Cancer Res (1993) 1.11

Large solitary fibrous tumor of the kidney: report of two cases and review of the literature. Am J Surg Pathol (2001) 1.11

Trisomy 18 syndrome with an unusual karyotype: possible double isochromosome. J Med Genet (1978) 1.10

Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol (1998) 1.10

Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. Cancer Res (1998) 1.10

Subtelomeric deletion of 18p in an adult with paranoid schizophrenia and mental retardation. Am J Med Genet A (2004) 1.10

STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia. Leukemia (2013) 1.10

The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies. Am J Clin Pathol (1984) 1.09

Coral disease diagnostics: what's between a plague and a band? Appl Environ Microbiol (2006) 1.08

Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia (2010) 1.08

High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities. Leukemia (2003) 1.07

Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am J Surg Pathol (1995) 1.06

Fluorescence in situ hybridization and spectral imaging of coral-associated bacterial communities. Appl Environ Microbiol (2006) 1.06

Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol (2001) 1.06

Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation. Bone Marrow Transplant (1993) 1.05

Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy. Am J Surg Pathol (1999) 1.05

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood (2001) 1.05

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant (2004) 1.05

Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol (2000) 1.05

Late degenerative changes in the cornea following breaks in Descemet's membrane. Trans Am Acad Ophthalmol Otolaryngol (1967) 1.05

Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis. Blood (2001) 1.05